Cheng S-S, Jiang J-G, Lin S-C, Yu Y-H, Chang TW, Lim C, Yu Y-B, Chu H-M. TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent ex vivo anti-myeloma activity. Haematologica 2026;111(4):1474-1477; https://doi.org/10.3324/haematol.2025.288692.